Bone Mineral Density Screening For Older Women With Normal T-Scores May Not Needed For 15 Years
January 22, 2012 by · Leave a Comment
The U.S. Preventive Services Task Force and other organizations have recommended that women ages 65 and older be routinely screened for osteoporosis using bone mineral density (BMD) screening. However, how often women should be screened is a topic that remains controversial and undecided, with no definitive scientific evidence to provide guidance. Now a new study led by Margaret L…
Healthy Minute: Get through menopause by reevaluating your health care needs
December 20, 2011 by · Leave a Comment
Menopause is called “the change” for a reason. As hormone levels begin to change, so do health concerns, such as osteoporosis, said experts at Baylor College of Medicine. “Decreasing estrogen levels can affect bone mass, making a woman more susceptible to osteoporosis,” said Dr. Elizabeth Nelson, associate professor of medicine and director of the Women’s Center for Comprehensive Care at BCM …
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
December 14, 2011 by · Leave a Comment
Postmenopausal females with osteoporosis or low bone mass who are on Prolia (denosumab) treatment were found to have continued increase in BMD (bone mineral density) for up to eight years, Amgen announced today at the meeting of the American Society for Bone and Mineral Research, San Diego, California…
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
December 7, 2011 by · Leave a Comment
Postmenopausal females with osteoporosis or low bone mass who are on Prolia (denosumab) treatment were found to have continued increase in BMD (bone mineral density) for up to eight years, Amgen announced today at the meeting of the American Society for Bone and Mineral Research, San Diego, California…
Partial Hysterectomies Still Increase Early Menopause Risk
November 29, 2011 by · Leave a Comment
A new study has suggests that preserving ovaries during hysterectomies may not reduce the risk for osteoporosis, cardiovascular disease and mortality.



















































